PharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024

/PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therapeutics to...

Related Keywords

Daejeon ,Taejon Gwangyoksi ,South Korea ,Venice Chiueh ,Taeweon Lee ,Wincal Biopharm Inc ,Association For Research ,Pharmabcine Inc ,Wincal Biopharm ,Ocular Penetration Carrier ,Chief Scientific Officer ,